Provided by Tiger Trade Technology Pte. Ltd.

Elanco Animal Health Inc

22.86
-0.6900-2.93%
Post-market: 23.080.2187+0.96%16:21 EDT
Volume:5.63M
Turnover:129.76M
Market Cap:11.42B
PE:-56.34
High:23.61
Open:23.37
Low:22.86
Close:23.55
52wk High:27.98
52wk Low:18.22
Shares:499.38M
Float Shares:492.94M
Volume Ratio:1.17
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4057
EPS(LYR):-0.4700
ROE:-2.98%
ROA:1.56%
PB:1.73
PE(LYR):-48.64

Loading ...

GUIDANCE: (ELAN) Elanco Animal Health Expects 2026 Adjusted EPS Range $1.03 to $1.09, vs. FactSet Est of $1.03

MT Newswires Live
·
May 06

BRIEF-Elanco Animal Health Q1 Revenue USD 1,371 Million Vs. IBES Estimate USD 1,288 Million

Reuters
·
May 06

Elanco Q1 FY26 adjusted EPS rises 8% to $0.40; revenue climbs 15% to $1.37 billion

Reuters
·
May 06

Elanco Animal Health Q1 Net Income USD 57 Million

THOMSON REUTERS
·
May 06

Elanco Animal Health Inc: in FY26, Anticipates Tailwind to REV of About $60 Mln From Favorable Impact of Foreign Exchange Rates

THOMSON REUTERS
·
May 06

Elanco Animal Health: Excl. Impacts of FX Rates & Royalty REV Sold, Expects Q2 Organic Constant Currency REV Growth of 4% to 6%

THOMSON REUTERS
·
May 06

Elanco Animal Health Q1 EPS USD 0.11

THOMSON REUTERS
·
May 06

Elanco Animal Health publishes 2025 annual report

Reuters
·
May 06

Elanco Animal Health announces annual shareholder meeting via virtual webcast

Reuters
·
May 04

ELAN 1Q Net Y949.00M Vs Net Y800.00M

Dow Jones
·
May 01

Elanco wins FDA emergency authorization for Negasunt against New World screwworm in livestock

Reuters
·
Apr 28

US FDA: Issued Emergency Use Authorization for Negasunt Powder to Prevent & Treat New World Screwworm in Multiple Species

THOMSON REUTERS
·
Apr 28

Elanco to report first-quarter results, host conference call

Reuters
·
Apr 16

Elanco Animal Health Initiated at Buy by Citigroup

Dow Jones
·
Apr 16

Elanco Animal Health announces annual shareholder meeting

Reuters
·
Apr 08

BUZZ-U.S. STOCKS ON THE MOVE-Delta, GATX, Humana

Reuters
·
Apr 08

BUZZ-J.P. Morgan upbeat on animal health companies ahead of Q1 results

Reuters
·
Apr 08

Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Alcon (ALC) and Elanco Animal Health (ELAN)

TIPRANKS
·
Apr 08

Elanco’s World Vaccine Congress Role Highlights Vaccine Pipeline And Investor Signals

Simply Wall St.
·
Apr 01

Assessing Elanco Animal Health’s Valuation After Its Strong 1 Year Total Return

Simply Wall St.
·
Mar 20